Google
Trusted Resources: Community Center
Online support, community stories, financial assistance
Amyloid Planet: Perspectives on Amyloidosis and Protein Misfolding Disorders
The most widely used system is the European modification of the original 3-stage Mayo 2004 system which uses Troponin T or I and NT-pro-BNP to divide patients into Stages 1, 2, 3a and 3b. The Mayo 2012 system, which incorporates serum free light chain levels, is another 4-stage variation on this theme.
Finally, there is a British cardiac staging system for transthyretin (ATTR) amyloidosis which was the subject of a prior amyloidosis JC discussion. What all of these publications have in common is the use of NT-pro-BNP as a key cardiac biomarker. What all medical centers don’t have in common is the ability to order this test without having to send out a blood sample.
myBinderRelated Content
-
Future AL Amyloidosis Treatmenthttps://www.youtube.com/watch?v=K25lurau...
-
Catherine Wong, MDDr. Wong worked as Assistant Professor o...
-
Q&A Session 2: More Answers to Patient Questions About AL Amyloidosishttps://www.youtube.com/watch?v=ZLUHc-sJ...
-
Troubleshooting Advice for Patients Taking Drugs for AL AmyloidosisAL amyloidosis is treated with the same ...
-
Roberto Coury PedrosaProfessional skills of Roberto Coury Ped...
-
Systemic Amyloidosis Recognition, Prognosis, and Therapy: A Systematic ReviewImportance: Many patients with systemic ...
-
U.S. Department of Veterans Affairs: AL Amyloidosis and Agent OrangeAL Amyloidosis and Agent Orange Veteran...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
